Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden
β Scribed by Zaher K. Otrock; Ali T. Taher; Wael A. Shamseddeen; Ghazi Zaatari; Ali Bazarbachi; Rami A. Mahfouz
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 93 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with malignant gliomas. To investigate the pathogenesis of VTE and facilitate targeted prophylaxis strategies, the authors aimed to characterize VTE risk factors in these patients. #
We describe a case of a 28-year-old man who developed an extensive spontaneous deep venous thrombosis. Testing revealed heterozygotic factor V Leiden mutation, and the presence of both lupus anticoagulant (LA) and elevated IgM anticardiolipin antibody (ACA). Several family members were found to be h
Factor V G1691A (FV-Leiden) and prothrombin (PRT) G20210A single nucleotide polymorphisms (SNPs) were associated with venous thrombosis among Caucasians. We assessed the contribution of both SNPs to the genetic susceptibility of deep venous thrombosis (DVT) among Lebanese and Tunisian patients. Subj